scispace - formally typeset
P

Patrick Auberger

Researcher at French Institute of Health and Medical Research

Publications -  240
Citations -  23380

Patrick Auberger is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 57, co-authored 229 publications receiving 20095 citations. Previous affiliations of Patrick Auberger include Institut de recherche pour le développement & University of Nice Sophia Antipolis.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

I. Ben Sahra, +16 more
- 05 Jun 2008 - 
TL;DR: Oral and intraperitoneal treatment with metformin led to a 50 and 35% reduction of tumor growth, respectively, in mice bearing xenografts of LNCaP, providing evidence for a mechanism that may contribute to the antineoplastic effects of met formin suggested by recent epidemiological studies.
Journal ArticleDOI

Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice

Gilles Pagès, +7 more
- 12 Nov 1999 - 
TL;DR: In p44 MAPK-/- thymocytes, proliferation in response to activation with a monoclonal antibody to the T cell receptor in the presence of phorbol myristate acetate was severely reduced even though activation of p42 MAPK was more sustained in these cells.